Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Juan L. Lopez-Canovas"'
Autor:
Natalia Herman-Sanchez, Juan L. Lopez-Canovas, Victor Amado, Javier M Zamora-Olaya, Manuel Rodriguez-Peralvarez, Raul M Luque, Gahete Manuel D.
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be645808832392e967ef1869cc29b503
https://doi.org/10.1530/endoabs.90.oc6.2
https://doi.org/10.1530/endoabs.90.oc6.2
Autor:
Natalia Herman Sanchez, Juan L Lopez-Canovas, Rio-Morenos Mercedes del, Victor Amado, la Mata Manuel de, Manuel Rodriguez-Peralvarez, Raul M Luque, Manuel D Gahete
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5cd6f7e1099b5e8b65546cd55e29dcec
https://doi.org/10.1530/endoabs.81.oc10.5
https://doi.org/10.1530/endoabs.81.oc10.5
Autor:
Vicente Herrero-Aguayo, Prudencio Sáez-Martínez, Juan M. Jiménez-Vacas, M. Trinidad Moreno-Montilla, Antonio J. Montero-Hidalgo, Jesús M. Pérez-Gómez, Juan L. López-Canovas, Francisco Porcel-Pastrana, Julia Carrasco-Valiente, Francisco J. Anglada, Enrique Gómez-Gómez, Elena M. Yubero-Serrano, Alejandro Ibañez-Costa, Aura D. Herrera-Martínez, André Sarmento-Cabral, Manuel D. Gahete, Raúl M. Luque
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 27, Iss , Pp 1164-1178 (2022)
Prostate-specific antigen (PSA) is the gold-standard marker to screen prostate cancer (PCa) nowadays. Unfortunately, its lack of specificity and sensitivity makes the identification of novel tools to diagnose PCa an urgent medical need. In this conte
Externí odkaz:
https://doaj.org/article/d4c45f418c84437da6d022bf2fddd485
Autor:
Juan L. López‐Cánovas, Natalia Hermán‐Sánchez, Maria Trinidad Moreno‐Montilla, Mercedes del Rio‐Moreno, Emilia Alors‐Perez, Marina E. Sánchez‐Frias, Víctor Amado, Rubén Ciria, Javier Briceño, Manuel de laMata, Justo P. Castaño, Manuel Rodriguez‐Perálvarez, Raúl M. Luque, Manuel D. Gahete
Publikováno v:
Clinical and Translational Medicine, Vol 12, Iss 11, Pp n/a-n/a (2022)
Abstract Introduction Altered splicing landscape is an emerging cancer hallmark; however, the dysregulation and implication of the cellular machinery controlling this process (spliceosome components and splicing factors) in hepatocellular carcinoma (
Externí odkaz:
https://doaj.org/article/44c65a5a43f5401cba4cff96e19ce370